ACADIAN ASSET MANAGEMENT LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 25 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q4 2021$120,000
+76.5%
55,813
+172.0%
0.00%
Q3 2021$68,000
-19.0%
20,516
-35.5%
0.00%
Q2 2021$84,000
+425.0%
31,793
+296.0%
0.00%
Q3 2020$16,000
+77.8%
8,029
+175.6%
0.00%
Q2 2020$9,000
+12.5%
2,9130.0%0.00%
Q1 2020$8,000
-42.9%
2,9130.0%0.00%
Q4 2019$14,000
-17.6%
2,9130.0%0.00%
Q3 2019$17,000
-10.5%
2,9130.0%0.00%
Q2 2019$19,0002,9130.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders